Advanced search
Instruments
| Name | Stock exchange | Average volume | Price | Type | ||
|---|---|---|---|---|---|---|
| LOCKHEED MARTIN CORPORATION | LMT | Buenos Aires S.E. +1 Other | 682 |
28,800
ARS
 | Stock | |
| LOCKHEED MARTIN CORPORATION | LMTD | Buenos Aires S.E. | 19 |
23.95
USD
| ||
| LOCKHEED MARTIN CORPORATION | LMTB34 | Sao Paulo | 40 |
2,418
BRL
| Stock | |
| LOCKHEED MARTIN CORPORATION | LMT | Nyse +11 Other | 708,628 |
467.4
USD
| Stock | |
| LOCKHEED MARTIN CORPORATION | LOM | Deutsche Boerse AG | 96 |
431.4
EUR
| ||
| LOCKHEED MARTIN CORPORATION | LOM | Frankfurt | 496 |
429.6
EUR
| ||
| LOCKHEED MARTIN CORPORATION | LMT * | Mexican S.E. | 301 |
7,700
MXN
| ||
| LOCKHEED MARTIN CORPORATION | LMT | Swiss Exchange | - |
430
CHF
| ||
| LOCKHEED MARTIN CORPORATION | 0R3E | London S.E. | 132 |
467.7
USD
| ||
| LOCKHEED MARTIN CORPORATION | LMT | Wiener Boerse | 9 |
432.6
EUR
| ||
| LOCKHEED MARTIN CORPORATION | LOM | Börse Stuttgart | 22 |
429.9
EUR
| ||
| LOCKHEED MARTIN CORPORATION | LOM | BOERSE MUENCHEN | 166 |
430.4
EUR
| ||
| LOCKHEED MARTIN CORPORATION | 4LMT | Borsa Italiana | - |
432.7
EUR
| ||
| LOCKHEED MARTIN CORPORATION | LMT | Berne S.E. | 3 |
414
CHF
| ||
| LOCKHEED MARTIN CORPORATION | LOM | Bulgaria S.E. | 1 |
439.1
EUR
| ||
| MARTIN MARIETTA MATERIALS, INC. | MLM | Nyse +6 Other | 389,516 |
579.2
USD
| Stock | |
| MARTIN MARIETTA MATERIALS, INC. | MMX | Deutsche Boerse AG | - |
529
EUR
| ||
| MARTIN MARIETTA MATERIALS, INC. | MLM * | Mexican S.E. | 16 |
10,105
MXN
| ||
| MARTIN MARIETTA MATERIALS, INC. | MMX | Börse Stuttgart | - |
530
EUR
| ||
| MARTIN MARIETTA MATERIALS, INC. | 0JZ0 | London S.E. | 6 |
584.8
USD
| ||
| MARTIN MARIETTA MATERIALS, INC. | MMX | BOERSE MUENCHEN | 10 |
533.6
EUR
| ||
| MARTIN MARIETTA MATERIALS, INC. | MMX | Berne S.E. | - | - CHF
| ||
| MAINSTAY MACKAY DEFINEDTERM MUNICIPAL OPPORTUNITIES FUND | MMD | Nyse | 51,823 |
16.33
USD
| Stock | |
| USHA MARTIN LIMITED | USHAMART | Bombay S.E. +1 Other | 50,649 |
355.6
INR
| Stock | |
| USHA MARTIN LIMITED | USHAMART | NSE India S.E. | 838,693 |
355.4
INR
| ||
| MARTIN BURN LIMITED | MARBU6 | Bombay S.E. | 1,540 |
50.5
INR
| Stock | |
| USHA MARTIN LIMITED | USHMA | LUXEMBOURG S.E. | - |
21.4
USD
| Stock | |
| MARTIN MIDSTREAM PARTNERS L.P. | MMLP | Nasdaq | 72,607 |
3.11
USD
| Stock | |
| MARTIN CURRIE GLOBAL PORTFOLIO TRUST PLC | MNP | London S.E. | 108,213 |
376
GBX
| Stock |
News (548)
Companies (73)
Lockheed Martin Corporation specializes in the design, manufacturing and marketing of aeronautic, submarine, and aerospace systems. Net sales break down by activity as follows: - sale of aeronautic systems (40.7%): military and civilian aircraft, primari ...
Jerónimo Martins, SGPS, S.A. is a Group that holds assets in the food sector, mostly in distribution, with market leadership positions in Poland and Portugal. In 2023, the Group recorded sales of 30.6 billion euros and an EBITDA of 2.2 billion euros. The ...
Martin Marietta Materials, Inc. is America's 2nd largest producer of granulates and construction materials. Net sales break down by family of products as follows: - granulates and construction materials (94.5%): granulates (58.7% of net sales), ready mix ...
Ahold Delhaize N.V. is one of the world leaders in retailing. Net sales break down by activity as follows: - retail distribution in the United States (61.5%): operated, at the end of 2023, 2,048 stores broken down by names between Food Lion (1,108), Stop ...
United Spirits Limited is India's largest spirits producer. The group provides Scotch (Black Dog, Dalmore, Jura and White & Mackay brands), Whisky (Antiquity, Bagpiper, McDowell's No.1 and McDowell's No.1 Platinum), rhum (Celebration rum), vodka (Pinky, R ...
Agrimin Limited is an Australia-based fertilizer development company. The principal activity of Company includes advancing the Mackay Potash Project in Western Australia. It operates in the area of mineral exploration and development in Western Australia. ...
Rémy Cointreau is one of the world's leading producers and distributors of cognac, spirits and liqueurs. Net sales break down by family of products as follows: - cognac (71%): Rémy Martin and LOUIS XIII brands; - liqueurs and spirits (27.1%): liqueur (C ...
Aston Martin Lagonda Global Holdings plc is a United Kingdom-based independent luxury car company. The Company has one operating segment, which is the automotive segment. The automotive segment includes all activities relating to design, development, manu ...
Hannan Metals Ltd. is a Canada-based natural resources and exploration company. The Companyâs projects include San Martin Copper Silver JOGMEC JV project, San Martin Hannan Project, Valiente Copper-Gold Project and Clare Regional Project. The San Martin ...
SM Energy Company s an independent energy company. The Company is engaged in the acquisition, exploration, development, and production of oil, gas, and natural gas liquid (NGL) in the state of Texas. The Companyâs asset portfolio is comprised of assets ...
Insiders
Martin W.
MacKay is the founder and currently holds the position of Chairman & Chief Executive Officer at Rallybio LLC, which was founded in 2018.
He is also the Executive Chairman at Rallybio Corp., founded in 2018.
In addition to his founding positions, Dr. MacKay currently serves as the Chief Executive Officer at Calyx Group Ltd.
(Ireland) and Rallybio Holdings LLC.
He is also a Director at Charles River Laboratories International, Inc., an Independent Director at Charles River Laboratories, Inc., and an Independent Director at Novo Nordisk A since 2018.
Dr. MacKay has held former positions as the Chief Executive Officer at Vecta Software Corp.
Ltd., Neverfail, Inc., and Neverfail Ltd.
He was also a Director at Encysive Pharmaceuticals, Inc. in 2008.
Additionally, he has served as the Operations Director at The Dun & Bradstreet Corp.
and Director-Business Development at NorthgateArinso, Inc. Dr. MacKay was an Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022.
He held the position of Senior Vice President-Worldwide Development at Pfizer Inc. from 1995 to 2009 and President-Research & Development at AstraZeneca PLC from 2010 to 2013.
From 2013 to 2017, he was the Global Head-Research & Development at Alexion Pharmaceuticals, Inc. Dr. MacKay has also held positions at VeriSign, Inc., BASF Performance Products Ltd.
(United Kingdom), New Leaf Venture Partners LLC, Pfizer (St. Louis), CRI Worldwide LLC, PeopleSoft USA, Inc., Accenture LLC, Ciba-Geigy Pharmaceuticals, and Beecham Pharmaceuticals (UK).
Dr. MacKay obtained a doctorate degree from The University of Edinburgh in 1984 and an undergraduate degree from Heriot-Watt University in 1979.
No results for this search
- Stock Market
- Advanced search
- Martin MacKay
